Sirtex Medical Limited (ASX:SRX) exited a trading halt on Friday, after announcing that it had received a second takeover bid from China-based CDH Investments at $33.60/share.
The new, conditional bid has led to Sirtex adjourning its shareholder meeting so that it can consider the proposal. Director’s fiduciary duties mandate that they must consider all options for maximising the value of shareholders, so the CDH Investments bid could lead to a delay in the Sirtex takeover process.
As we have reported previously, Sirtex is currently under a binding takeover offer from Varian Medical Systems, valuing Sirtex at $28 per share. The Sirtex Board has unanimously voted in favour, and the Foreign Investment Review Board (FIRB) announced that it had no objection to the takeover. The final step was to have shareholders vote on the arrangement.
However, the CDH bid has now thrown somewhat of a spanner in the works, by delaying the proposed shareholder meeting. Indeed, it’s possible the bid may have been lobbed deliberately late, in an attempt to either frustrate Varian’s attempt or try to achieve a stronger bargaining position for CDH.
There is a chance that the CDH bid goes through, and there could be an ‘arbitrage’ opportunity available (buy shares at $29 today and sell them at $33.60 if the CDH bid eventuates). However, it is far from a certainty that a higher bid will emerge – either from CDH or from Varian. CDH may just wish to get a look at Sirtex’s books to better evaluate what it is worth.
In my opinion, shareholders should watch from the sidelines for now.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
Motley Fool contributor Sean O'Neill owns shares of Sirtex Medical Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Results: Is G8 Education Ltd a buy for its 4% dividend? – August 27, 2018 12:22pm
- Results: Why the Adacel Technologies Limited (ASX:ADA) share price is down 7% – August 26, 2018 9:54pm
- Results: Why the Nearmap Ltd (ASX:NEA) share price is up 4% today – August 22, 2018 5:15pm